The US Food and Drug Administration (FDA) has taken action against companies that distribute kratom with disease-treatment claims and has said sellers must warn consumers about serious risks instead of presenting these products as safe, simple wellness aids
[23] Additionally, a 2018 observational study suggested an elevated risk of developing inflammatory bowel disease, specifically ulcerative colitis, which peaked after three to four years of use and decreased after more than four years
an alteration in a biological response in the presence of the VEGFR2-blocking, anti-VEGF antibody of the invention is indicative of a response mediated by the VEGFR2 receptor
The idea behind GLP-1 probiotics is interesting and makes sense on paper, but right now the evidence only supports their role in gut health, not in suppressing appetite or driving weight loss, says Dr
The results revealed that the drastic inhibition of GLP-1 secretion, caused by the shutdown of the main pathway via the SSTRs-Gi axis, is the main cause of pasireotide-induced hyperglycemia
)
